Fungicidal activity of IFN-gamma-activated macrophages. Extracellular killing of Cryptococcus neoformans
- PMID: 2496162
Fungicidal activity of IFN-gamma-activated macrophages. Extracellular killing of Cryptococcus neoformans
Abstract
Cryptococcus neoformans is an encapsulated yeast-form fungus which causes pulmonary and meningeal infections preferentially in the immunocompromised host. It is thought that cell-mediated immunity is important for acquired resistance against cryptococcosis with activated macrophages as the final effector cells. However, specific polysaccharides in the capsule of C. neoformans protect the fungus from adherence to phagocytes and from subsequent phagocytosis. We have studied extracellular killing of C. neoformans by IFN-gamma-activated macrophages and their products. Murine bone marrow-derived macrophages stimulated with rIFN-gamma for 24 h were able to effectively suppress the growth of C. neoformans and the effect of IFN-gamma was augmented by LPS. Killing of C. neoformans was also achieved by cell-free supernatants from bone marrow-derived macrophages stimulated with IFN-gamma plus LPS. Our results indicate that killing of C. neoformans by activated macrophages is independent from toxic oxygen radicals and mediated by secreted protein(s) of apparent molecular mass of 15 and 30 kDa. These findings indicate that activated macrophages play a major role in host defense, although the fungus resists phagocytosis and remains in the extracellular milieu.
Similar articles
-
Paradoxical role of capsule in murine bronchoalveolar macrophage-mediated killing of Cryptococcus neoformans.J Immunol. 1989 Jan 15;142(2):659-65. J Immunol. 1989. PMID: 2521352
-
Cryptococcus neoformans inhibits nitric oxide production by murine peritoneal macrophages stimulated with interferon-gamma and lipopolysaccharide.Cell Immunol. 1997 Aug 25;180(1):47-54. doi: 10.1006/cimm.1997.1166. Cell Immunol. 1997. PMID: 9316638
-
Effect of granulocyte-macrophage colony-stimulating factor on rat alveolar macrophage anticryptococcal activity in vitro.J Immunol. 1994 Jan 15;152(2):724-34. J Immunol. 1994. PMID: 8283047
-
Catch me if you can: phagocytosis and killing avoidance by Cryptococcus neoformans.FEMS Immunol Med Microbiol. 2012 Mar;64(2):147-61. doi: 10.1111/j.1574-695X.2011.00871.x. FEMS Immunol Med Microbiol. 2012. PMID: 22029633 Review.
-
[Up-to-date findings in the host defence mechanism to cryptococcus infection].Med Mycol J. 2014;55(3):J107-14. doi: 10.3314/mmj.55.j107. Med Mycol J. 2014. PMID: 25231225 Review. Japanese.
Cited by
-
In vivo activation of macrophage oxidative burst activity by cytokines and amphotericin B.Infect Immun. 1990 May;58(5):1296-300. doi: 10.1128/iai.58.5.1296-1300.1990. Infect Immun. 1990. PMID: 2157668 Free PMC article.
-
Activation of human peripheral blood mononuclear cells by interleukin-2 and granulocyte-macrophage colony-stimulating factor to inhibit Cryptococcus neoformans.Infect Immun. 1991 Oct;59(10):3393-7. doi: 10.1128/iai.59.10.3393-3397.1991. Infect Immun. 1991. PMID: 1894353 Free PMC article.
-
IFN-γ immune priming of macrophages in vivo induces prolonged STAT1 binding and protection against Cryptococcus neoformans.PLoS Pathog. 2018 Oct 10;14(10):e1007358. doi: 10.1371/journal.ppat.1007358. eCollection 2018 Oct. PLoS Pathog. 2018. PMID: 30304063 Free PMC article.
-
A T cell-independent protective host response against Cryptococcus neoformans expressed at the primary site of infection in the lung.Infect Immun. 1993 Dec;61(12):5302-8. doi: 10.1128/iai.61.12.5302-5308.1993. Infect Immun. 1993. PMID: 7901167 Free PMC article.
-
Mouse-human immunoglobulin G1 chimeric antibodies with activities against Cryptococcus neoformans.Antimicrob Agents Chemother. 1994 Jul;38(7):1507-14. doi: 10.1128/AAC.38.7.1507. Antimicrob Agents Chemother. 1994. PMID: 7979280 Free PMC article.